Lewes, DE -- (SBWire) -- 07/23/2013 --LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: International Stem Cell Corp (OTCMKTS:ISCO), Obscene Jeans Corp. (OTCBB:OBJE), Guided Therapeutics Inc (OTCBB:GTHP),FANNIE MAE PFD S (OTCBB:FNMAS)

International Stem Cell Corp (OTCMKTS:ISCO) declined -3.33% recently, while trading on 263,288.00 shares, at the price of $0.145. The stock changed hands in a range of $0.14 to $0.15 up till now, bringing its market capitalization at about $16.29M. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.14 on Jul 22, 2013 and was moved to the maximum level of $0.41 on Feb 12, 2013. International Stem Cell Corporation is a developmental-stage biotechnology company. The Company focused on therapeutic, biomedical and cosmeceutical product.

Has ISCO Found The Bottom and Ready To Move Up? Find Out Here

Obscene Jeans Corp. (OTCBB:OBJE) added 2.85% recently, in the current trading session, at $0.310 with a total volume of 259,379.00 shares. The stock, on average, trades on a volume of 186,103.00 shares. It floated in a range of $0.28 to $0.32. Its market capitalization now moved to about $3.86M. In the past 52 weeks, the share price has not declined below $0.25 or above $3.90. OBJ Enterprises, Inc., a development stage company, focuses to design, develop, manufacture, market, wholesale, distribute, and sell a women’s line of ‘Obscene Brand jeans’.

For How Long OBJE Gloss will Attract Investors? Find out via this report

Guided Therapeutics Inc (OTCBB:GTHP) recently recorded a fall of -1.58% and was moving within a range of $0.68 -$0.70, its current trading price is $0.687. The stock is moving up till now with a total volume of 302,948.00 shares, versus an average volume of 88,385.00 shares. The share price hit its 52-week low of $0.52 on Dec 4, 2012 and $0.98 was the best price in the same period. Guided Therapeutics, Inc., formerly SpectRx, Inc., is a medical technology company focused on developing medical devices. Its primary focus is the development of its cervical cancer detection technology (LightTouch) and extension of its cancer detection platform into other cancers, especially lung and esophageal.

Why Should Investors Buy GTHP After the Recent Fall? Just Go Here and Find Out

FANNIE MAE PFD S (OTCBB:FNMAS) loss of -0.40% in its current trading activity, bringing its market capitalization around $1.40B. The share price, after opening at $4.99, hit a high of $5.09 and hovered above $4.94, while its recent trading price was $4.97. The total number of shares changed hands during the current session up till now was 364,447.00 shares, as compared to average trading volume of 1.71M shares. Federal National Mortgage Association (Fannie Mae) provides liquidity and stability support services in the secondary mortgage market in the United States. The company securitizes mortgage loans originated by lenders in the primary mortgage market into Fannie Mae mortgage-backed securities (Fannie Mae MBS).

Will FNMAS Get Buyers Even After The Recent Rally? Find Out Here

About LeadingStockAlerts:
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.

Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.

Disclaimer:
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/